FDA approves multifocal toric IOL

Alcon has received FDA approval for its AcrySof IQ ReStor +3.0D multifocal toric IOL for adult patients with cataracts.

The company says the IOL, designed to treat both presbyopia and pre-existing corneal astigmatism, will be available in early 2017.

“Correcting presbyopia and astigmatism, with one lens, at the time of cataract surgery is a great benefit to patients and can improve patient satisfaction,” said Dr. Stephen Lane, medical director for Associated Eye Care and adjunct clinical professor at the University of Minnesota. “The introduction of this advanced technology IOL gives us an additional treatment option to help reduce dependence on spectacles for patients with astigmatism.”

The lens is already available in the European Union, Australia, Canada, and many countries in Central and South America and Asia.